Inventor
BOZIK MICHAEL E
US26 patents
⚠️ This page may combine multiple inventors who share the name “BOZIK MICHAEL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KNOPP BIOSCIENCES LLC
18 patentsUS9468630B2Oct 18, 2016
Compositions and methods for treating conditions related to increased eosinophils
KNOPP BIOSCIENCES LLC14 citations91
US11724990B2Aug 15, 2023
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC4 citations85
US10851067B2Dec 1, 2020
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC6 citations83
US9642840B2May 9, 2017
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
KNOPP BIOSCIENCES LLC10 citations83
US9956206B2May 1, 2018
Compositions and methods for treating amyotrophic lateral sclerosis in responders
KNOPP BIOSCIENCES LLC4 citations80
US9662313B2May 30, 2017
Compositions and methods for treating amyotrophic lateral sclerosis in responders
KNOPP BIOSCIENCES LLC6 citations80
US11261162B2Mar 1, 2022
KV7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC3 citations72
US10195183B2Feb 5, 2019
Compositions and methods for treating chronic urticaria
KNOPP BIOSCIENCES LLC3 citations72
US10028940B2Jul 24, 2018
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
KNOPP BIOSCIENCES LLC3 citations72
US9763918B2Sep 19, 2017
Compositions and methods for treating chronic urticaria
KNOPP BIOSCIENCES LLC4 citations72
US11026928B2Jun 8, 2021
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
KNOPP BIOSCIENCES LLC3 citations71
US10980783B2Apr 20, 2021
Compositions and methods for treating conditions related to increased eosinophils
KNOPP BIOSCIENCES LLC2 citations71
US10828284B2Nov 10, 2020
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
KNOPP BIOSCIENCES LLC1 citations71
US10383856B2Aug 20, 2019
Compositions and methods for treating conditions related to increased eosinophils
KNOPP BIOSCIENCES LLC2 citations71
US10383857B2Aug 20, 2019
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
KNOPP BIOSCIENCES LLC2 citations71
US9849116B2Dec 26, 2017
Compositions and methods of using (R)-pramipexole
KNOPP BIOSCIENCES LLC3 citations71
US10456381B2Oct 29, 2019
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
KNOPP BIOSCIENCES LLC0 citations51
US10285981B2May 14, 2019
Compositions and methods for treating amyotrophic lateral sclerosis in responders
KNOPP BIOSCIENCES LLC0 citations48
BOZIK MICHAEL E
3 patentsUS8524695B2Sep 3, 2013
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
BOZIK MICHAEL E11 citations81
US8518926B2Aug 27, 2013
Compositions and methods of using (R)-pramipexole
BOZIK MICHAEL E13 citations81
US8445474B2May 21, 2013
Compositions of R(+) and S(−) pramipexole and methods of using the same
BOZIK MICHAEL E11 citations81
ARETEIA THERAPEUTICS INC
2 patentsUS11612589B2Mar 28, 2023
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
ARETEIA THERAPEUTICS INC1 citations68
US12138249B2Nov 12, 2024
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
ARETEIA THERAPEUTICS INC0 citations58